Tie2 kinase inhibitor 1 : A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models

GNE-7883 : Cooperation between the Hippo and MAPK pathway activation drives acquired resistance to TEAD inhibition